NCT06972537View on ClinicalTrials.gov

A Study on the Infusion Regimen of Piperacillin-Tazobactam in Patients Aged 65 and Older With Pneumonia

NARecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Pneumonia
Interventions
DRUG

Increase the frequency and extended infusion time of Piperacillin Sodium and Tazobactam Sodium for Injection (Bonda) 4.5g

Piperacillin Sodium and Tazobactam Sodium for Injection (Bonda) 4.5g administered four times a day (QID), with each infusion lasting for 4 hours.

DRUG

Extended Infusion Time of Piperacillin Sodium and Tazobactam Sodium for Injection (Bonda), 4.5g

Piperacillin Sodium and Tazobactam Sodium for Injection (Bonda), 4.5g administered three times a day (TID), with each infusion lasting for 3 hours.

Trial Locations (1)

250000

RECRUITING

Second hospital of Shandong university, Jinan

All Listed Sponsors
lead

Shandong University

OTHER